Simonetta Maria Leto

6PUBLICATIONS
53CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 28, 2026
Efficacy of dual KRASG12D-EGFR blockade versus triple combinations in patient-derived models of KRASG12D-mutant colorectal cancer.

|Sep 22, 2025
The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer.

Marco Avolio, Simonetta M Leto, Francesco Sassi

|Aug 29, 2024
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients.

Simonetta M Leto, Elena Grassi, Marco Avolio

|Feb 09, 2023
Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT).

Marta Falcinelli, Giulia Dell'Omo, Elena Grassi

|Jan 09, 2023
Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer.

Simonetta M Leto, Martina Ferri, Francesco Sassi

|Feb 24, 2022
Effective drug combinations in breast, colon and pancreatic cancer cells.

Patricia Jaaks, Elizabeth A Coker, Daniel J Vis

Pageof 1

Frequent Collaborators

6 joint publications

Livio Trusolino

5 joint publications

Elena Grassi

3 joint publications

Andrea Bertotti

2 joint publications

Valentina Vurchio